Detalhe da pesquisa
1.
Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes.
Int J Mol Sci
; 25(10)2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791405
2.
Apolipoprotein-CIII O-Glycosylation, a Link between GALNT2 and Plasma Lipids.
Int J Mol Sci
; 24(19)2023 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37834292
3.
Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans.
Front Endocrinol (Lausanne)
; 14: 1081741, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36926036
4.
Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry.
Front Chem
; 9: 678883, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34026735
5.
Metformin and statin use associate with plasma protein N-glycosylation in people with type 2 diabetes.
BMJ Open Diabetes Res Care
; 8(1)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616483